Page last updated: 2024-11-02

1,7-dimethylxanthine and Pulmonary Disease, Chronic Obstructive

1,7-dimethylxanthine has been researched along with Pulmonary Disease, Chronic Obstructive in 1 studies

1,7-dimethylxanthine : A dimethylxanthine having the two methyl groups located at positions 1 and 7. It is a metabolite of caffeine and theobromine in animals.

Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.

Research Excerpts

ExcerptRelevanceReference
"In the second model, in blood of COPD-patients and healthy controls ex vivo pre-incubated with a physiological concentration of 1,7-dimethylxanthine (10microM), LPS-induced production of the cytokines IL-6 and TNF-alpha was significantly suppressed."1.36Inhibition of acute pulmonary and systemic inflammation by 1,7-dimethylxanthine. ( Bast, A; Brauers, K; Geraets, L; Haegens, A; Hageman, GJ; Vernooy, JH; Weseler, AR; Wouters, EF, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Geraets, L1
Haegens, A1
Weseler, AR1
Brauers, K1
Vernooy, JH1
Wouters, EF1
Bast, A1
Hageman, GJ1

Other Studies

1 other study available for 1,7-dimethylxanthine and Pulmonary Disease, Chronic Obstructive

ArticleYear
Inhibition of acute pulmonary and systemic inflammation by 1,7-dimethylxanthine.
    European journal of pharmacology, 2010, Mar-10, Volume: 629, Issue:1-3

    Topics: Administration, Oral; Aged; Animals; Anti-Inflammatory Agents; Benzamides; Case-Control Studies; Cyt

2010